Interleukin-12: Cellular and Molecular Immunology of an Important Regulatory Cytokine. New York, 9-12 November 1996: Introduction

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages

  Lotze, M T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN RECEPTOR;

ANIMAL CELL; CONFERENCE PAPER; DISULFIDE BOND; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGY; MOUSE; NONHUMAN; T LYMPHOCYTE;

EID: 0030446306     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52649.x     Document Type: Conference Paper

References (37)

1. 1 Carrel, A. 1924. Leukocyte trephones. JAMA 82: 255–258.
2. 2 Kasakura, S. & L. Lowenstein. 1965. A factor stimulating DNA synthesis derived from the medium of leucocyte cultures. Nature 208: 794–795.
3. 3 Gordon, J. & L. D. MacLean. 1965. A lymphocyte‐stimulating factor produced in vitro. Nature 208: 795–796.
4. 4 Morgan, D. A., F. W. Rusetti & R. G. Gouro. 1976. Selective in vitro growth of T‐lymphocytes from normal bone marrow. Science 193: 1007–1008.
5. 5 Taniguchi, T. & Y. Minami. 1993. The IL‐2/IL‐2 receptor system: A current over‐view. Cell 73: 5–8.
6. 6 Voss, S. D., P. M. Sondel & R. J. Robb. 1992. Characterization of the interleukin 2 receptors (IL‐2R) expressed on human natural killer cells activated in vivo by IL‐2: Association of the p64 IL‐2R g chain with the IL‐2β chain in functional intermediate‐affinity IL‐2R. J. Exp. Med. 176: 531–541.
7. 7 Noguchi, M., H. Yi, H. M. Rosenblatt, A. H. Filipovich, S. Adelstein, W. S. Modi, O. W. McBride & W. J. Leonard. 1993. Interleukin‐2 Receptor γ chain mutation results in x‐linked severe combined immunodeficiency in humans. Cell 73: 147–157.
8. 8 Kondo, M., T. Takeshita, N. Ishii, M. Nakamura, S. Watanabe, K. Arai & K. Sugamura. 1993. Sharing of the interleukin‐2 (IL‐2) receptor γ chain between receptors for IL‐2 and IL‐4. Science 262: 1874–1877.
9. 9 Aversa, G., J. Punnonen, B. G. Cocks, R. de Waal Malefyt, F. Vega, Sm. Zurawski, G. Zurawski & J. E. de Vries. 1993. An interleukin 4 (IL‐4) mutant protein inhibits both IL‐4 or IL‐13 induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: Support for a common component shared by IL‐4 and IL‐13 receptors. J. Exp. Med. 178: 2213–2218.
10. 10 Germann, T., H. Huhn, F. Zimmermann & E. Rude. 1987. An antigen‐independent physiological activation pathway for L3T4 + T lymphocytes. Eur. J. Immunol. 17: 775–781.
11. 11 Germann, T., S. C. Jin, F. Mattner & E. Rude. 1991. Components of an antigen‐/T cell receptor‐independent pathway of lymphokine production. Eur. J. Immunol. 21: 1357–1361.
12. 12 Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chang, R. Loudon, F. Sherman, B. Perussia & G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827–845.
13. 13 Gately, M. K., D. E. Wilson & H. L. Wong. 1986. Synergy between recombinant interleukin 2 (rIL2) and IL2‐depleted lymphokine‐containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro J. Immunol. 136: 1274–1282.
14. 14 Wong, H. L., D. E. Wilson, J. C. Jenson, P. C. Familletti, D. L. Stremlo & M. Gately. 1988. Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T‐lymphocyte responses in vitro. Cell. Immunol. 111: 39–54.
15. 15 Stern, A. S., F. J. Podlaski, J. D. Hulmes, Y. C. E. Pan, P. M. Quinn, A. G. Wolitzky, P. C. Familletti, D. L. Stremlo, T. Truitt, R. Chizzonite & M. K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B‐lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87: 6808–6812.
16. 16 Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chang, R. Loudon, F. Sherman, B. Perussia & G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827–845.
17. 17 Wolf, S. F., P. A. Temple, M. Kobayashi, E. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri & B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effect on T and natural killer cells. J. Immunol. 146: 3074–3081.
18. 18 Gubler, U., A. O. Chua, D. S. Schoenhout, C. M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A. G. Wolitzky, P. M. Quinn, P. C. Familletti & M. K. Gately. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88: 4143–4147.
19. 19 Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark & G. Trinchieri. 1991. Induction of Interferon‐γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173: 869–879.
20. 21 Novelli, F., M. Giovarelli, R. Reber‐Liske, G. Virgallita, G. Garotta & G. Forni. 1991. Blockade of physiologically secreted IFN‐γ inhibits human T lymphocyte and natural killer cell activation. J. Immunol. 147: 1445–1452.
21. 22 Gately, M. K., B. B. Desai, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, F. J. Podlaski, P. C. Familletti, F. Sinigalia, R. Chizzonite, U. Gubler & A. S. Stern. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL‐12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147: 874–882.
22. 23 Gately, M. K., B. B. Desai, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, F. J. Podlaski, P. C. Familletti, U. Gubler & A. S. Stern. 1991. Interleukin‐12: A novel heterodimeric cytokine with potential antitumor applications. Neuroimmunol. Res. 4: 20–32.
23. 24 Naume, B., M. Gately & T. Espevik. 1992. A comparative study of IL‐12 (cytotoxic lymphocyte maturation factor)‐, IL‐2‐, and IL‐7‐induced effects on immunomagnetically purified CD56 + NK cells. J. Immunol. 148: 2429–2436.
24. 25 Hsieh, C‐S., S. Macatonia, C. Tripp, S. Wolf, A. O'Garra & K. Murphy. 1993. Development of Th1 CD4 + T cells through IL‐12 produced by Listeria ‐induced macrophages. Science 260: 547–549.
25. 26 Afonso, L. C. C., T. M. Scharton, L. Q. Vieira. M. Wysocka, G. Trinchieri & P. Scott. 1994. The adjuvant effect of interleukin‐12 in a vaccine against Leishmania major. Science 263: 235–237.
26. 27 Tahara, H., H. Zeh, W. J. Storkus, I. Pappo, S. Watkins, M. K. Gately, U. Gubler, S. F. Wolf, P. D. Robbins & M. T. Lotze. 1994. Fibroblasts genetically engineered to secrete interleukin‐12 can suppress tumor growth in vivo and induce antitumor immunity to a murine melanoma. Cancer Res. 54: 182–189.
27. 28 Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, K. Murphy, S. F. Wolf & M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin‐12 against murine tumors. J. Exp. Med. 178: 1223–1230.
28. 29 Nastala, C. L., H. Edington, W. Storkus, T. G. McKinney, M. Brunda, M. Gately, S. F. Wolf, R. Chrieber & M. T. Lotze. 1994. Recombinant interleukin‐12 induces tumor regression in murine models: Interferon‐gamma but not nitric oxide dependent effects. J. Immunol. 153: 1697–1706.
29. 30 Fardoun‐Joalland, D., G. Teixeira‐Lebrun, B. Lenormand, M. Dzondo‐Gadet & J. P. Vannier. 1995. Synergism of interleukin‐12 and interleukin‐3 on development of hematopoietic progenitors. Eur. J. Haematol. 54 (3): 172–175.
30. 31 Hirao, A., Y. Takaue, Y. Kawano, J. Sato, T. Suzue, T. Abe, S. Saito, M. Kawahito, Y. Okamoto, A. Makimoto, et al. 1995. Synergism of interleukin 12, interleukin 3 and serum factor on primitive human hematopoietic progenitor cells. Stem Cells 13: 47–53.
31. 32 Jacobsen, S. E. W., C. Okkenhaug, J. Myklebust, O. P. Belby & S. D. Lyman. 1995. The FLT3 ligand potently and directly stimulates the growth and expansion of primitive bone marrow progenitor cell in vitro: Synergistic interactions with interleukin (IL) 11, IL‐12, and other hematopoietic growth factors. J. Exp. Med. 181: 1357–1363.
32. 33 Tare, N. S., S. Bowen, R. R. Warrier, D. M. Carvajal, W. R. Benjamin, J. H. Riley, T. D. Anderson & M. K. Gately. 1995. Administration of recombinant interleukin‐12 to mice suppresses hematopoiesis in the bone marrow but enhances hematopoiesis in the spleen. J. Interferon Cytokine Res. 15: 377–383.
33. 34 Eng, V. M., B. D. Car, B. Schnyder, M. Lorenz, S. Lugli, M. Aguet, T. D. Anderson, B. Ryffel & V. F. Guesniaux. 1995. The stimulatory effects of interleukin (IL)‐12 on hematopoiesis are antagonized by IL‐12‐induced interferon gamma in vivo. J. Exp. Med. 181: 1893–1898.
34. 35 Shurin, M. R., P. P. Pandharipande & M. T. Lotze. FLT3: Receptor and ligand biology and potential clinical application. Submitted for publication.
35. 36 Freedman, A. R., H. Zhu, J. D. Levine, S. Kalams & D. T. Scadden. 1996. Generation of human T lymphocytes from bone marrow CD34 + cells in vitro. Nature Med. 2: 46–52.
36. 37 Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda & M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN‐γ production by T‐cells. Nature 378: 88–92.
37. 38 Magrem, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C‐Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty & M. K. Gately. 1996. IL‐12‐defkient mice are defective in IFN‐γ production and Type 1 cytokine responses. Immunity 4: 471–482.